Patents by Inventor Hidetada Sasaki

Hidetada Sasaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150216714
    Abstract: [Problem] To catch excreta whether a person is sitting or supine and essentially independent of movements of the person's body. [Solution] The diaper unit is configured from: an outer diaper wrapper (2), which encloses an artificial gluteal block constructed from an elastic member and which is provided with a cover (20) on which hook end loop fasteners (26aa) are provided at least on the portion that faces a person's gluteal region when worn; and an inner diaper wrapper (3) provided with a main diaper body (30), which has an opening (36) at the section of the diaper for handling feces and which adheres to the outer diaper wrapper (2) by means of the hook and loop fasteners (26aa) of the outer diaper wrapper (2), and a fecal bag (40) the interior of which is water-absorbing and the exterior of which is waterproof, which is bonded to the opening (36) of the diaper body (30) and is accommodated in a hole in the outer diaper wrapper.
    Type: Application
    Filed: November 7, 2013
    Publication date: August 6, 2015
    Inventors: Hidetada Sasaki, Masahiko Fujii, Masaji Komoda
  • Patent number: 8410175
    Abstract: An object of the present invention is to provide an enhancing agent for effect of anticancer agent for achieving an excellent therapeutic effect on cancer. The enhancing agent for effect of anticancer agent according to the present invention which is a solving means therefor is characterized in that a nitric oxide donor is an effective ingredient. In accordance with the present invention, an excellent therapeutic effect is able to be achieved on non-small cell lung cancer which is still in such a state that no effective therapeutic method has been established yet for a progressive cancer which is not operable and is one of cancers where chemotherapy is most difficult to apply.
    Type: Grant
    Filed: December 22, 2008
    Date of Patent: April 2, 2013
    Assignee: Nippon Kayaku Kabushiki Kaisha
    Inventors: Hiroyasu Yasuda, Mutsuo Yamaya, Katsutoshi Nakayama, Hidetada Sasaki
  • Patent number: 7838494
    Abstract: The present invention provides an agent comprising HGF for inducing differentiation of bone marrow cells into alveolar cells. The present invention also provides an HGF-containing agent for alveolar formation in pulmonary emphysema and the like in which alveoli are destroyed.
    Type: Grant
    Filed: March 7, 2005
    Date of Patent: November 23, 2010
    Assignees: Tohoku Technoarch Co., Ltd., Kringle Pharma Inc.
    Inventors: Hiroshi Kubo, Kota Ishizawa, Hidetada Sasaki, Toshikazu Nakamura
  • Publication number: 20090137683
    Abstract: An object of the present invention is to provide an enhancing agent for effect of anticancer agent for achieving an excellent therapeutic effect on cancer. The enhancing agent for effect of anticancer agent according to the present invention which is a solving means therefor is characterized in that a nitric oxide donor is an effective ingredient. In accordance with the present invention, an excellent therapeutic effect is able to be achieved on non-small cell lung cancer which is still in such a state that no effective therapeutic method has been established yet for a progressive cancer which is not operable and is one of cancers where chemotherapy is most difficult to apply.
    Type: Application
    Filed: December 22, 2008
    Publication date: May 28, 2009
    Applicant: Nippon Kayaku Kabushiki Kaisha
    Inventors: Hiroyasu Yasuda, Mutsuo Yamaya, Katsutoshi Nakayama, Hidetada Sasaki
  • Publication number: 20080039521
    Abstract: An object of the present invention is to provide an enhancing agent for effect of anticancer agent for achieving an excellent therapeutic effect on cancer. The enhancing agent for effect of anticancer agent according to the present invention which is a solving means therefor is characterized in that a nitric oxide donor is an effective ingredient. In accordance with the present invention, an excellent therapeutic effect is able to be achieved on non-small cell lung cancer which is still in such a state that no effective therapeutic method has been established yet for a progressive cancer which is not operable and is one of cancers where chemotherapy is most difficult to apply.
    Type: Application
    Filed: June 10, 2005
    Publication date: February 14, 2008
    Inventors: Hiroyasu Yasuda, Mutsuo Yamaya, Katsutoshi Nakayama, Hidetada Sasaki
  • Publication number: 20070197433
    Abstract: The present invention provides an agent comprising HGF for inducing differentiation of bone marrow cells into alveolar cells. The present invention also provides an HGF-containing agent for alveolar formation in pulmonary emphysema and the like in which alveoli are destroyed.
    Type: Application
    Filed: March 7, 2005
    Publication date: August 23, 2007
    Inventors: Hiroshi Kubo, Kota Ishizawa, Hidetada Sasaki, Toshikazu Nakamura
  • Publication number: 20070142279
    Abstract: The present invention provides an agent for promoting induction of differentiation of bone marrow cells into endothelial progenitor cells capable of being differentiated into endothelial cells, comprising hepatocyte growth factor as an active ingredient, and such agent is useful in the field of medical therapy or regenerative medicine.
    Type: Application
    Filed: March 7, 2005
    Publication date: June 21, 2007
    Inventors: Hiroshi Kubo, Kota Ishizawa, Hidetada Sasaki, Toshikazu Nakamura
  • Publication number: 20050026186
    Abstract: The present invention provides a method for evaluating an inclination of a subject to lung cancer, the method comprising preparing a DNA, from the sample, containing at least one allele which comprises a GT repeat located upstream to a heme oxygenase-1 gene, and determining the repeat number of the GT repeat in each allele in the sample wherein the presence of at least one allele comprising a GT repeat whose repeat number is not less than 33 being an indication for an inclination of a subject to lung cancer. In addition, the present invention provides a kit for evaluating an inclination of a subject to lung cancer, by means of the method.
    Type: Application
    Filed: May 28, 2004
    Publication date: February 3, 2005
    Inventors: Mutsuo Yamaya, Hiroshi Kubo, Satoshi Suzuki, Hidetada Sasaki
  • Patent number: 6436645
    Abstract: An objective of this invention is to provide a method for predicting the risk of subject developing chronic pulmonary emphysema. To achieve the objective, this invention provides a method for predicting the risk of subject developing chronic pulmonary emphysema comprising determining the number of GT repeats within a GT repeat sequence located upstream of hemeoxygenase-1, in which if the number of the GT repeats is not less than 30, the subject has a high risk of developing chronic pulmonary emphysema.
    Type: Grant
    Filed: November 22, 2000
    Date of Patent: August 20, 2002
    Assignee: President of Tohoku University
    Inventors: Hidetada Sasaki, Shoji Okinaga, Mutsuo Yamaya, Katsutoshi Nakayama
  • Patent number: D757932
    Type: Grant
    Filed: May 20, 2013
    Date of Patent: May 31, 2016
    Assignee: UNICARE CORP.
    Inventors: Hidetada Sasaki, Masahiko Fujii, Masaji Komoda
  • Patent number: D767123
    Type: Grant
    Filed: May 20, 2013
    Date of Patent: September 20, 2016
    Assignee: UNICARE CORP.
    Inventors: Hidetada Sasaki, Masahiko Fujii, Masaji Komoda